Vivos (RDGL) EPS (Diluted) Growth (5y) (2016 - 2025)
Vivos (RDGL) EPS (Diluted) Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn |
| 10 | Vivos | 26.71 Mn | 25.15 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -155.73% |
| Sep 30, 2025 | -157.96% |
| Jun 30, 2025 | -162.27% |
| Mar 31, 2025 | -135.02% |
| Dec 31, 2024 | -133.04% |
| Sep 30, 2024 | -110.01% |
| Jun 30, 2024 | -143.96% |
| Mar 31, 2024 | -142.67% |
| Dec 31, 2023 | -28.83% |
| Sep 30, 2023 | 1.47% |
| Jun 30, 2023 | -41.41% |
| Mar 31, 2023 | -60.17% |
| Dec 31, 2022 | -60.38% |
| Sep 30, 2022 | -43.16% |
| Jun 30, 2022 | -83.69% |
| Mar 31, 2022 | -10.92% |
| Dec 31, 2021 | -21.20% |
| Sep 30, 2021 | -5.22% |
| Jun 30, 2021 | 14.96% |
| Mar 31, 2021 | 45.15% |